Drug Trial Radar · NCT04353778
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
215
Actual
Start
Aug 3, 2020
Primary completion
Mar 27, 2026
Study completion Mar 27, 2026
Sponsor
- Lead sponsor
- Icahn School of Medicine at Mount SinaiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Apr 20, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that SIBO is associated with signs of inflammation in the blood of people living with HIV (PLWH). This research will explore pathways linking vagal dysfunction to inflammation in HIV, focusing on the gastrointestinal tract, and study whether a medication called pyridostigmine and stimulation of the vagus nerve are beneficial therapies.
Conditions
- HIV
- Non-HIV
- Vagus Nerve Dysfunction
Interventions
PyridostigmineDrug
Eight weeks of low-dose pyridostigmine
PlacebosDrug
matching placebo x 8 weeks
non-invasive vagal nerve stimulationProcedure
stimulation of the vagus nerve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Small bowel transit time (SBTT)Time frame: 8 weeks
- Gastric pH measurementTime frame: 8 weeks
- Hydrogen/methane breath testing (hbt)Time frame: 8 weeks
- IL6 measurement [Time Frame: 5 years]Time frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Icahn School of Medicine at Mount Sinai
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.